Microgram: The DEA Western Laboratory (San Francisco, California) recently received two exhibits of apparent Ecstasy tablets, all 9 millimeters in diameter by 4 millimeters thick, suspected MDMA (see Photos 7 and 8 (colors not true)). The exhibits were acquired by the Santa Clara County Sheriff's Office (no further details). [...] The second exhibit contained two multicolored speckled pink tablets (total net mass 256 milligrams) with a crown logo. Analysis of both exhibits by GC and GC/IRD, however, identified not MDMA but rather a mixture of ketamine, methamphetamine, and dimethylsulfone. The drug components were not formally quantitated, but were estimated as [...] 1.4 percent ketamine and 0.7 percent methamphetamine in the crown logo tablets. This is believed to be the first submission of Ecstasy mimic tablets containing a mixture of ketamine and methamphetamine to the Western Laboratory.

Support EcstasyData.org

Should the public have access to independent analysis of the products they consume?

The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.

EcstasyData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $90,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.